Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹915 Cr₹997 Cr₹364 Cr₹791 Cr₹605 Cr

What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Operating Activities ratio of GLAND PHARMA is ₹915 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹915 Cr
Mar2024₹997 Cr
Mar2023₹364 Cr
Mar2022₹791 Cr
Mar2021₹605 Cr

How is Cash Flow from Operating Activities of GLAND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹915 Cr
-8.23
Mar2024 ₹997 Cr
173.87
Mar2023 ₹364 Cr
-53.97
Mar2022 ₹791 Cr
30.72
Mar2021 ₹605 Cr -

Compare Cash Flow from Operating Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹36,055.0 Cr 0.2% -6.5% 24.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,104.0 Cr 3.5% -1.5% 9% Stock Analytics
DIVIS LABORATORIES ₹180,119.0 Cr 1.1% -1.1% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,871.0 Cr -0.2% -0.3% 35% Stock Analytics
CIPLA ₹114,334.0 Cr 3.1% 1% -11.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,761.0 Cr 1.1% -2.1% -5.6% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.2%

-6.5%

24.3%

SENSEX

1.1%

2.4%

-5%


You may also like the below Video Courses